UV INK LUS-210 BLACK

Hazard statements (CLP)

H315, H317, H319, H360, H400, H410, H411

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

No additional information available

Hazard pictograms

GHS07 GHS08 GHS09

Signal word

Danger

Contains

Hexamethylene diacrylate; 4-(1-oxo-2-propenyl)-morpholine; diphenyl(2,4,6- trimethylbenzoyl)phosphine oxide

Hazard statements

H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H360 - May damage fertility or the unborn child. H410 - Very toxic to aquatic life with long lasting effects.

Precautionary statements

P201 - Obtain special instructions before use. P261 - Avoid breathing mist, vapours, spray. P280 - Wear protective gloves, eye protection, face protection. P308+P313 - IF exposed or concerned: Get medical advice/attention. P273 - Avoid release to the environment. P391 - Collect spillage.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII (75980-60-8) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide The substance is not included in the list established in accordance with Article 59(1) of (75980-60-8) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Skin sensitisation, Category 1 H317 Reproductive toxicity, Category 1B H360 Hazardous to the aquatic environment – Acute Hazard, Category 1 H400 Hazardous to the aquatic environment – Chronic Hazard, Category 2 H411 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available